Anzeige
Mehr »
Dienstag, 22.07.2025 - Börsentäglich über 12.000 News
100% seit April - und trotzdem erst der Anfang? Kupfer wird zum Turbo-Rohstoff des Jahres!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQ1X | ISIN: CA0717341071 | Ticker-Symbol: BVF
Tradegate
21.07.25 | 18:26
5,378 Euro
-0,76 % -0,041
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BAUSCH HEALTH COMPANIES INC Chart 1 Jahr
5-Tage-Chart
BAUSCH HEALTH COMPANIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,3315,49009:30
5,4105,41009:30

Aktuelle News zur BAUSCH HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBest Stock to Buy Right Now: Bausch Health vs Canopy Growth?49
12.07.Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel5
11.07.Bausch Health Companies Inc: Bausch Health appoints Lee as chief accounting officer3
10.07.Bausch Health Companies Inc: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, CABTREO, Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs577LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene...
► Artikel lesen
10.07.Bausch Health Companies Inc: Bausch Health Appoints New Chief Accounting Officer392LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Steven Lee as Senior...
► Artikel lesen
10.07.Bausch Health Companies Inc. - 8-K, Current Report3
09.07.Bausch Health Companies Inc: Bausch's Cabtreo treatment available thru fed programs1
08.07.Bausch Health Companies Inc: Bausch Health begins Xifaxan campaign3
BAUSCH HEALTH Aktie jetzt für 0€ handeln
07.07.Bausch Health Companies Inc.: Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan for Adults at Risk of Overt Hepatic Encephalopathy Recurrence243Focused on highlighting real patient experiences, Salix continues to lead the charge in educating and advocating for the hepatic encephalopathy community LAVAL, QC / ACCESS Newswire / July 7, 2025 /...
► Artikel lesen
02.07.Stocks in Play: Bausch Health Companies6
02.07.Bausch Health Companies Inc: Bausch Health to release Q2 2025 results July 306
02.07.Bausch Health Companies Inc.: Bausch Health to Announce Second Quarter 2025 Results on July 30240LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch...
► Artikel lesen
27.06.Bausch Health Companies Inc. - 8-K, Current Report9
18.06.Bausch Health Companies Inc. - 8-K, Current Report16
14.06.Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds38
13.06.Bausch Health ticks higher following large director stock purchase24
10.06.Bausch Health Companies Inc. - 8-K, Current Report16
15.05.Bausch Health Companies Inc: Bausch Health shareholders approve AGM resolutions20
14.05.Bausch Health Companies Inc: Bausch Health Announces 2025 Annual Meeting of Shareholder Results532LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual...
► Artikel lesen
14.05.Bausch Health Companies Inc. - 8-K, Current Report10
Weiter >>
120 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,11